logo
AI Iconš›¼SK or Search
ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

129
Analysis
Health Care ā€¢ United States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
bullishā€¢Regeneron Pharmaceuticals
ā€¢03 May 2026 15:45

Primer: Regeneron Pharmaceuticals (REGN US) - May 2026

Regeneron's growth is propelled by the strong performance of its blockbuster drugs, Eylea HD and Dupixent, with the latter continuing to expand...

Logo
Share
bullishā€¢Regeneron Pharmaceuticals
ā€¢23 Sep 2025 10:45

Primer: Regeneron Pharmaceuticals (REGN UW) - Sep 2025

Regeneron's growth is propelled by the strong performance of its blockbuster drugs, Eylea and Dupixent, alongside a promising and extensive...

Logo
Share

Copyright Ā© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x